Cargando…
Chinese medicinal herbs for idiopathic membranous nephropathy in adults with nephrotic syndrome: A systematic review of effectiveness and safety
To assess the benefits and harms of Chinese medicinal herbs formulae for the treatment of idiopathic membranous nephropathy in adult patients with primary nephrotic syndrome. Only randomized controlled trials were included. We searched the Cochrane Central Register of Controlled Trials database, Pub...
Autores principales: | Liu, Meifang, Yang, Qianchun, Hua, Qiaoli, Liu, Jialing, He, Weifeng, Niu, Di, Liu, Xusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677963/ https://www.ncbi.nlm.nih.gov/pubmed/34918644 http://dx.doi.org/10.1097/MD.0000000000027953 |
Ejemplares similares
-
Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021) -
Comparison of efficacy and safety of traditional Chinese patent medicines for diabetic nephropathy: A protocol for Bayesian network meta-analysis
por: Liu, Shilin, et al.
Publicado: (2022) -
Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022) -
Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021) -
Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)